[1. Cieślik E., Kościej A. Kwas foliowy – występowanie i znaczenie. Probl Hig Epidemiol. 2012; 93(1): 1–7.]Search in Google Scholar
[2. Bomba–Opoń D, Hirnle L, Kalinka Ji wsp. Suplementacja folianów w okresie przedkoncepcyjnym, w ciąży i połogu. Rekomendacje Polskiego Towarzystwa Ginekologów i Położników. Gin Perinat Prakt. 2017; 2, 5: 210–214.]Search in Google Scholar
[3. Paul L, Selhub J. Interaction between excess folate and low vitamin B12 status. Mol Aspects Med. 2017; 53: 43–47.10.1016/j.mam.2016.11.004]Open DOISearch in Google Scholar
[4. National Institutes of Health. Office of Dietary Supplemensts. Folate. Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Folate-HealthProfessional/. Dostęp: 25.02.2019.]Search in Google Scholar
[5. Kerr SM, Parker SE, Mitchell AA et al. Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects. Ann Epidemiol. 2017: 27(12); 777–782.10.1016/j.annepidem.2017.10.010]Open DOISearch in Google Scholar
[6. Putta S, Pennell PB. Management of epilepsy during pregnancy: evidence–based strategies. Future Neurol. 2015; 10 (2): 161–176.10.2217/fnl.15.4]Search in Google Scholar
[7. Viale L, Allotey J, Cheong-See F et al. Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Lancet. 2015; 386(10006): 1845–1852.10.1016/S0140-6736(15)00045-8]Search in Google Scholar
[8. Gooneratne I.K, Wimalaratna M, Ranaweera AKP et al. Contraception advice for women with epilepsy. BMJ. 2017; 357:j2010.10.1136/bmj.j201028495788]Search in Google Scholar
[9. Van Gool JD, Hirche H, Lax H et al. Folic acid and primary prevention of neural tube defects: A review. Reprod Toxicol. 2018; 80:73–84.10.1016/j.reprotox.2018.05.00429777755]Open DOISearch in Google Scholar
[10. Turgal M, Gumruk F, Karaagaoglu E et al. Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome. Geburtshilfe Frauenheilkde. 2018: 78(09); 871–878.3025824710.1055/a-0664-8237613847230258247]Search in Google Scholar
[11. Servy EJ, Jacquesson-Fournols L, Cohen M et al.MTHFR isoform carriers. 5-MTHF (5-methyl tetrahydrofolate) vs folic acid: a key to pregnancy outcome: a case series. J Assist Reprod Genet. 2018: 35(8); 1431–1435.10.1007/s10815-018-1225-2608679829882091]Search in Google Scholar
[12. Whitrow MJ., Moore VM., Rumbold AR. et al. Effect of Supplemental Folic Acid in Pregnancy on Childhood Asthma: A Prospective Birth Cohort Study. Am J Epidemiol. 2009; 170(12): 1486–1493.10.1093/aje/kwp31519880541]Search in Google Scholar
[13. Trivedi MK., Sharma S., Rifas–Shiman SL. Et al. Folic Acid in Pregnancy and Childhood Asthma: A US Cohort. Clin Pediatr. 2018; 57(4): 421–427.10.1177/0009922817729482582374628884603]Open DOISearch in Google Scholar
[14. Vereen S., Gebretsadik T., Johnson N. Association Between Maternal 2nd Trimester Plasma Folate Levels and Infant Bronchiolitis. Matern Child Health J. 2018; 23(2): 164–172.10.1007/s10995-018-2610-2633960730027465]Search in Google Scholar
[15. Imbard A, Benoist JF, Blom H. Neural Tube Defects, Folic Acid and Methylation. Int J Environ Res Public Health. 2013: 10(9); 4352–4389.10.3390/ijerph10094352379952524048206]Open DOISearch in Google Scholar
[16. Greene NDE, Copp AJ. Neural Tube Defects. Annu Rev Neurosci. 2014: 37(1); 221–242.10.1146/annurev-neuro-062012-170354448647225032496]Open DOISearch in Google Scholar
[17. Bagłaj M. Wady dysraficzne: wielospecjalistyczne postępowanie. Stowarzyszenie na Rzecz Dzieci z Rzadkimi Chorobami Genetycznymi i Ich Rodzin Wspólnie. http://wspolnie.org/wady-dysraficzne/. Dostęp: 25.02.2019.]Search in Google Scholar
[18. Liu S, Joseph KS, Luo W et al. Effect of Folic Acid Food Fortification in Canada on Congenital Heart Disease Subtypes Clinical Perspective. Circulation. 2016: 134(9); 647–655.10.1161/CIRCULATIONAHA.116.022126499812627572879]Search in Google Scholar
[19. Linask KK, Huhta J. Folate protection from congenital heart defects linked with canonical Wnt signaling and epigenetics. Curr Opin Pediatr. 2010: 22(5); 561–566.10.1097/MOP.0b013e32833e2723300428520844350]Open DOISearch in Google Scholar
[20. Van Beynum IM, Kapusta L, Bakker MK et al. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry–based case–control study in the northern Netherlands. Eur Heart J. 2009: 31(4); 464–471.10.1093/eurheartj/ehp47919952004]Search in Google Scholar
[21. Groen in’t Woud S, Renkema KY, Schreuder MF et al. Maternal risk factors involved in specific congenital anomalies of the kidney and urinary tract: A case–control study. Birth Defects Res A Clin Mol Teratol. 2016: 106(7);596–603.10.1002/bdra.2350027040999]Search in Google Scholar
[22. Canfield MA, Collins JS, Botto LD et al. Changes in the birth prevalence of selected birth defects after grain fortification wiht folic acid in the United States: Findings from a multi-state population–based study. Birth Defects Res A Clin Mol Teratol. 2005: 73(10); 679–689.10.1002/bdra.2021016240378]Search in Google Scholar
[23. Godwin KA., Sibbald B., Bedard T et al. Changes in Frequencies of Select Congenital Anomalies since the Onset of Folic Acid Fortification in a Canadian Birth Defect Registry. Can J Public Health. 2008;99(4):271-5.10.1007/BF03403753]Search in Google Scholar